These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33640923)

  • 1. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
    Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs.
    Arasaradnam RP; Bhala N; Evans C; Greenaway J; Logan R; Penman I; Seward E; Singh B; Smith S; Stephenson JA; Waugh N;
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):717-719. PubMed ID: 32526209
    [No Abstract]   [Full Text] [Related]  

  • 3. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
    Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
    Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model to prioritize waiting lists for elective surgery under the COVID-19 pandemic pressure.
    Valente R; Di Domenico S; Mascherini M; Santori G; Papadia F; Orengo G; Gratarola A; Cafiero F; De Cian F;
    Br J Surg; 2021 Jan; 108(1):e12-e14. PubMed ID: 33640936
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing.
    Tolley T; Whewell H; Davies DR; Codd RJ; Swarnkar KJ; Williams GL
    Br J Surg; 2021 Apr; 108(3):e119-e120. PubMed ID: 33793747
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 9. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used?
    Benton SC; Fraser CG
    Ann Clin Biochem; 2021 May; 58(3):163-165. PubMed ID: 33016079
    [No Abstract]   [Full Text] [Related]  

  • 10. The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing.
    Maclean W; Singh R; Mackenzie P; White D; Benton S; Stebbing J; Rockall T; Jourdan I
    Ann R Coll Surg Engl; 2020 Apr; 102(4):308-311. PubMed ID: 32081023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting a 2-week-wait colorectal service in the pandemic using the quantitative faecal immunochemical test.
    Cock K; Bromley R; Faux W
    Br J Nurs; 2021 Apr; 30(7):404-408. PubMed ID: 33830800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    D'Souza N; Abulafi M
    Br J Surg; 2020 Jun; 107(7):e204. PubMed ID: 32400893
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program.
    Malani K; Elfanagely Y; Promrat K
    J Gastrointest Cancer; 2024 Sep; 55(3):1460-1462. PubMed ID: 38764007
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of COVID-19 on advanced colorectal cancer.
    Burns EM; Boyle K; Mirnezami A; Jenkins JT;
    Colorectal Dis; 2020 Jul; 22(7):737-738. PubMed ID: 32705789
    [No Abstract]   [Full Text] [Related]  

  • 15. Stage migration of colorectal cancer during COVID-19 pandemic.
    Liyanage ASD; Gokul K; Babu BH; Ainsworth P
    Br J Surg; 2020 Oct; 107(11):e477. PubMed ID: 32876950
    [No Abstract]   [Full Text] [Related]  

  • 16. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the COVID-19 pandemic on colorectal cancer service provision.
    CRC COVID Research Collaborative
    Br J Surg; 2020 Oct; 107(11):e521-e522. PubMed ID: 32856751
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 19. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
    Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
    Abdellatif M; Salama Y; Alhammali T; Eltweri AM
    Br J Surg; 2021 Apr; 108(4):e146-e147. PubMed ID: 33792641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.